Early detection of lung cancer through breath analysis
Develop a non-invasive device that analyzes breath samples to detect early signs of lung cancer, allowing for timely interventions. The device can detect volatile organic compounds released by cancer cells. Market Size: The global lung cancer diagnostics market size is projected to reach $3.5 billion by 2027.
Breath analysis
United States
